BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17996488)

  • 1. Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells.
    Pan C; Yan M; Yao J; Xu J; Long Z; Huang H; Liu Q
    Oral Oncol; 2008 Jul; 44(7):639-45. PubMed ID: 17996488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells.
    Xu DR; Huang S; Long ZJ; Chen JJ; Zou ZZ; Li J; Lin DJ; Liu Q
    J Transl Med; 2011 May; 9():74. PubMed ID: 21600017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia.
    Huang XF; Luo SK; Xu J; Li J; Xu DR; Wang LH; Yan M; Wang XR; Wan XB; Zheng FM; Zeng YX; Liu Q
    Blood; 2008 Mar; 111(5):2854-65. PubMed ID: 18160664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensional culture.
    Long ZJ; Xu J; Yan M; Zhang JG; Guan Z; Xu DZ; Wang XR; Yao J; Zheng FM; Chu GL; Cao JX; Zeng YX; Liu Q
    Cell Cycle; 2008 May; 7(10):1473-9. PubMed ID: 18418083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells.
    Guan Z; Wang XR; Zhu XF; Huang XF; Xu J; Wang LH; Wan XB; Long ZJ; Liu JN; Feng GK; Huang W; Zeng YX; Chen FJ; Liu Q
    Cancer Res; 2007 Nov; 67(21):10436-44. PubMed ID: 17974987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VX-680 inhibits Aurora A and Aurora B kinase activity in human cells.
    Tyler RK; Shpiro N; Marquez R; Eyers PA
    Cell Cycle; 2007 Nov; 6(22):2846-54. PubMed ID: 18032922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora-A down-regulates IkappaBalpha via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival.
    Yao JE; Yan M; Guan Z; Pan CB; Xia LP; Li CX; Wang LH; Long ZJ; Zhao Y; Li MW; Zheng FM; Xu J; Lin DJ; Liu Q
    Mol Cancer; 2009 Nov; 8():95. PubMed ID: 19891769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Aurora-A results in increased cell death in 3-dimensional culture microenvironment, reduced migration and is associated with enhanced radiosensitivity in human nasopharyngeal carcinoma.
    Wan XB; Fan XJ; Chen MY; Xu J; Long ZJ; Hua YJ; Ji H; Liu L; Hong MH; Zeng YX; Liu Q
    Cancer Biol Ther; 2009 Aug; 8(15):1500-6. PubMed ID: 19502819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.
    Kaestner P; Stolz A; Bastians H
    Mol Cancer Ther; 2009 Jul; 8(7):2046-56. PubMed ID: 19584233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells.
    Wan XB; Long ZJ; Yan M; Xu J; Xia LP; Liu L; Zhao Y; Huang XF; Wang XR; Zhu XF; Hong MH; Liu Q
    Carcinogenesis; 2008 Oct; 29(10):1930-7. PubMed ID: 18667445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the aurora kinases suppresses in vitro NT2-D1 cell growth and tumorigenicity.
    Ulisse S; Arlot-Bonnemains Y; Baldini E; Morrone S; Carocci S; Di Luigi L; D'Armiento M
    J Endocrinol; 2010 Feb; 204(2):135-42. PubMed ID: 19889886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trivalent dimethylarsenic compound induces histone H3 phosphorylation and abnormal localization of Aurora B kinase in HepG2 cells.
    Suzuki T; Miyazaki K; Kita K; Ochi T
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):275-82. PubMed ID: 19716834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
    Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
    Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma.
    Mahadevan D; Stejskal A; Cooke LS; Manziello A; Morales C; Persky DO; Fisher RI; Miller TP; Qi W
    Clin Cancer Res; 2012 Apr; 18(8):2210-9. PubMed ID: 22374334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy.
    Hoar K; Chakravarty A; Rabino C; Wysong D; Bowman D; Roy N; Ecsedy JA
    Mol Cell Biol; 2007 Jun; 27(12):4513-25. PubMed ID: 17438137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora kinase inhibitor VX-680 enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy.
    Kou J; Wang X; Wei Y; Zhao R; Wang X; He J; Li X; Wang X
    Anticancer Drugs; 2021 Oct; 32(9):969-977. PubMed ID: 34016831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo.
    Faisal A; Vaughan L; Bavetsias V; Sun C; Atrash B; Avery S; Jamin Y; Robinson SP; Workman P; Blagg J; Raynaud FI; Eccles SA; Chesler L; Linardopoulos S
    Mol Cancer Ther; 2011 Nov; 10(11):2115-23. PubMed ID: 21885865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of the Aurora kinase inhibitor VX-680 for Hepatoblastoma.
    Dewerth A; Wonner T; Lieber J; Ellerkamp V; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Pediatr Surg Int; 2012 Jun; 28(6):579-89. PubMed ID: 22526548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB694, a novel antimitotic with antitumor activities.
    Weiderhold KN; Randall-Hlubek DA; Polin LA; Hamel E; Mooberry SL
    Int J Cancer; 2006 Feb; 118(4):1032-40. PubMed ID: 16152590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells.
    Choi JE; Woo SM; Min KJ; Kang SH; Lee SJ; Kwon TK
    Oncol Rep; 2015 Mar; 33(3):1395-401. PubMed ID: 25592064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.